We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Axovant Sciences Ltd. (AXON - Free Report) was a big mover last session, as the company saw its shares rise a little above 9% on the day. The upside was driven by the company’s encouraging corporate and financial developments. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 47% in the past one-month time frame.
The company has seen one negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate moved lower over the same timeframe suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Axovant Sciences currently carries a Zacks Rank #3 (Hold).
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public. Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Axovant Sciences (AXON) Shows Strength: Stock Jumps 9.2%
Axovant Sciences Ltd. (AXON - Free Report) was a big mover last session, as the company saw its shares rise a little above 9% on the day. The upside was driven by the company’s encouraging corporate and financial developments. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 47% in the past one-month time frame.
The company has seen one negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate moved lower over the same timeframe suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Axovant Sciences currently carries a Zacks Rank #3 (Hold).
Axovant Sciences Ltd. Price
Axovant Sciences Ltd. Price | Axovant Sciences Ltd. Quote
A better-ranked stock in the Medical – Biomedical and Genetics industry is Anthera Pharmaceuticals, Inc. (ANTH - Free Report) sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>